MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Transcranial direct current stimulation-related changes in postural responses to perturbations are not influenced by baseline clinical characteristics in Parkinson’s disease.

    V. Beretta, R. Vitório, D. Orcioli-Silva, N. Conceição, P. Nóbrega-Sousa, M. Pereira, L. Gobbi (Rio Claro, Brazil)

    Objective: To investigate the association between clinical characteristics and transcranial direct current stimulation (tDCS)-related changes in postural responses to external perturbations in people with Parkinson’s…
  • MDS Virtual Congress 2021

    Effectiveness of an intensive and structured therapy (LSVT-BIG) in comparison to conventional therapy for people with Parkinson’s disease in Singapore.

    D. Maniam, JQ. Yong, V. Tan (Singapore, Singapore)

    Objective: The aim of the study was to investigate if Lee Silverman Voice Therapy BIG (LSVT)-BIG®  programme was more effective than conventional physiotherapy for People…
  • MDS Virtual Congress 2021

    Validity and Reliability of Timed Get-Up and Go Test and Unified Parkinson’s disease Rating Scales on Parkinson ’s disease

    T. T (Bangalore, India)

    Objective: This study is an attempt to find the inter-rater and intra-rater reliability of both timed up and go test and unified Parkinson’s rating scale.…
  • MDS Virtual Congress 2021

    People living with Parkinson’s disease during the COVID-19 Pandemic: A cross-sectional survey of the Canadian experience

    M. Mckeown, T. Mestre, E. Crighton (Ottawa, Canada)

    Objective: To explore the how the COVID-19 pandemic has changed healthcare experiences for people living with Parkinson’s disease (PwP) in Canada. Background: Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Freezing of gait in Parkinson’s disease: A 4-item FOG-Quick questionnaire assessment

    W. Phuenpathom, O. Phokaewvarangkul, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To translate and validate a Thai language version of the FOG-Q. In addition, to develop a short-version 4-item question or FOG-Quick questionnaire was developed.…
  • MDS Virtual Congress 2021

    Outcomes of Gene therapy and Subsequent Deep Brain Stimulation for Parkinson’s Disease

    Y. Chintaluru, J. Thomspon, P. David Gerecht, S. Ojemann, D. Kern (Aurora, USA)

    Objective: The purpose of this study is to determine the outcomes of patients who received GAD gene therapy treatment and subsequently underwent DBS for Parkinson’s…
  • MDS Virtual Congress 2021

    GPi DBS for refractory dystonia 4 years after STN DBS on a Parkinson’s Disease patient

    B. Meira, A. Santos, C. Reizinho, R. Barbosa, M. Mendonça, P. Bugalho (Lisbon, Portugal)

    Objective: Describe a case of unilateral globus pallidus internus (GPi) deep brain stimulation (DBS) for refractory dystonia after subthalamic nucleus (STN) DBS on a Parkinson…
  • MDS Virtual Congress 2021

    Measures of Physical Activity in Parkinson’s Disease (MAPD)

    J. Gilby, C. Carroll, J. Marsden (Plymouth, United Kingdom)

    Objective: This study assessed the concurrent validity, feasibility and perceived utility of two different modalities of capturing physical activity (PA) in people with newly diagnosed…
  • MDS Virtual Congress 2021

    A metadata-driven tool to determine the robustness of digital health technologies assessments for Parkinson’s disease leveraging the voice of the patient

    S. Sardar, R. Bhatnagar, R. Badawy, J. Burton, V. Aggarwal, K. Romero, M. Minchik, M. Spott, D. Hill, J. Cosman, C. Lansdall, G. Stebbins, N. Zach, M. Frasier, T. Hastings, M. Javidnia, J. Duffen, H. Matthews, M. Lawton, D. Dexter, N. Ratcliffe, K. Fisher, L. Oliva, S. Jones, A. Dowling, M. Meinders, L. Evers, B. Bloem, J. Cedarbaum, M. Muller, D. Stephenson (Tucson, USA)

    Objective: To develop a decision tool for assessing the robustness of digital health technology (DHT)-based measures in Parkinson’s disease (PD) using  a patient-centric approach. Background: Development of effective therapeutics in PD is hampered by the lack of drug development…
  • MDS Virtual Congress 2021

    Nurse-led rapid access mental health clinic: a new care pathway in Parkinson’s disease

    S. Lidstone, K. Marcelle (Toronto, Canada)

    Objective: To provide rapid evaluation and non-pharmacological treatment of mental health symptoms in Parkinson's disease (PD) patients and their caregivers. Background: Mental health problems are…
  • « Previous Page
  • 1
  • …
  • 421
  • 422
  • 423
  • 424
  • 425
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley